Polymeric membrane lactobacillus formulation for use in type II diabetes.

用于治疗 II 型糖尿病的聚合物膜乳酸菌制剂。

• 批准号: 172053
• 负责人: Prakash Satya
• 金额: $ 28.13万
• 依托单位: McGill University
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2008
• 资助国家: 加拿大
• 起止时间: 2008-09-01 至 2011-09-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=172053&lang=en
• 关键词: Diabetes Mellitus; Feruloyl Esterase; Microcpsule; Polymeric Membrane

Recent changes in human diet and lifestyle have resulted in a dramatic increase in number of diabetics worldwide. The continuous use of currently available synthetic drugs has associated limitations. This proposal is an attempt to address the urgent need

最近人类饮食和生活方式的变化导致全球糖尿病患者数量急剧增加。继续使用现有合成药物具有相关的局限性。这项建议是为了解决迫切需要